Lung Cancer
Studies from Vrije University in the Area of Lung Cancer Published
Published in Cancer Weekly, January 25th, 2011
2011 JAN 25 -- According to recent research published in the journal European Radiology, "We investigated the feasibility of serial dynamic contrast-enhanced computed tomography (DCE-CT) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) receiving anti-angiogenic (sorafenib) and anti-EGFR (erlotinib) treatment, and correlated tumour blood flow (BF) with treatment outcome. DCE-CTs were performed at baseline and 3 and 6 weeks after starting treatment."
"Tumour BF, calculated with the maximum slope method, and percentage change were measured in 23 patients (14 male; median age 59 years). Tumour BF was compared at baseline and weeks...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-01-25)
More Articles from Cancer Weekly
- Medicare and Medicaid
AARP Backs Idaho Cig. Tax Hike - Cancer Nursing
Data on Cancer Nursing Described by Researchers at University Medical Center - Genetics and Familial Cancer
Data on Genetics and Familial Cancer Detailed by Researchers at Uppsala University - Nanotechnology - Nanorods
Data on Nanotechnology - Nanorods Described by Researchers at Fudan University - Pancreatic Cancer
Findings in Pancreatic Cancer Reported from University of Sao Paulo - Colon Cancer
For non-whites, geography plays key role in colon cancer screening - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
